{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T02:58:13Z","timestamp":1785380293376,"version":"3.55.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["RS-2024-00332244"],"award-info":[{"award-number":["RS-2024-00332244"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.diagmicrobio.2026.117405","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T15:43:10Z","timestamp":1775230990000},"page":"117405","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of the AccuPower HIV-1 Quant Kit and Aptima HIV-1 Quant Dx Assay for quantification of HIV-1 plasma viral load"],"prefix":"10.1016","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6405-5305","authenticated-orcid":false,"given":"Tae Yeul","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minhee","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Jin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Jae","family":"Huh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2026.117405_bib0001","doi-asserted-by":"crossref","first-page":"946","DOI":"10.7326\/0003-4819-126-12-199706150-00003","article-title":"Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection","volume":"126","author":"Mellors","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.diagmicrobio.2026.117405_bib0002","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S1473-3099(09)70321-4","article-title":"Diagnosis and management of antiretroviral-therapy failure in resource-limited settings in sub-Saharan Africa: challenges and perspectives","volume":"10","author":"Harries","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2026.117405_bib0003","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2165","article-title":"HIV-1 viral load testing in resource-limited settings: challenges and solutions for specimen integrity","volume":"31","author":"Newman","year":"2021","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.diagmicrobio.2026.117405_bib0004","unstructured":"European AIDS Clinical Society. EACS guidelines version 13.0. 2025. https:\/\/www.eacsociety.org\/guidelines\/eacs-guidelines\/(Accessed Dec 18, 2025)."},{"key":"10.1016\/j.diagmicrobio.2026.117405_bib0005","series-title":"Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach","year":"2016"},{"key":"10.1016\/j.diagmicrobio.2026.117405_bib0006","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1001\/jama.2020.17025","article-title":"Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2020 recommendations of the international antiviral society-USA panel","volume":"324","author":"Saag","year":"2020","journal-title":"Jama"},{"key":"10.1016\/j.diagmicrobio.2026.117405_bib0007","doi-asserted-by":"crossref","unstructured":"Summary of 2021 clinical guidelines for the diagnosis and treatment of HIV\/AIDS in HIV-infected Koreans. Infect Chemother 2021;53:592-616.","DOI":"10.3947\/ic.2021.0305"},{"key":"10.1016\/j.diagmicrobio.2026.117405_bib0008","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jcv.2017.05.006","article-title":"Comparison of the Hologic Aptima HIV-1 Quant DX Assay to the Roche COBAS Ampliprep\/COBAS TaqMan HIV-1 test v2.0 for the quantification of HIV-1 RNA in plasma samples","volume":"92","author":"Sch\u00f8nning","year":"2017","journal-title":"J Clin Virol"},{"key":"10.1016\/j.diagmicrobio.2026.117405_bib0009","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jcv.2019.03.008","article-title":"Multicenter evaluation of the cobas\u00ae HIV-1 quantitative nucleic acid test for use on the cobas\u00ae 4800 system for the quantification of HIV-1 plasma viral load","volume":"114","author":"Adams","year":"2019","journal-title":"J Clin Virol"},{"key":"10.1016\/j.diagmicrobio.2026.117405_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2020.104530","article-title":"Multicenter clinical comparative evaluation of Alinity m HIV-1 assay performance","volume":"129","author":"Braun","year":"2020","journal-title":"J Clin Virol"},{"key":"10.1016\/j.diagmicrobio.2026.117405_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2020.104644","article-title":"Evaluation of the Alinity m HIV-1 assay for the quantification of HIV-1 RNA plasma viral load in a high-throughput molecular laboratory in South Africa","volume":"132","author":"Maree","year":"2020","journal-title":"J Clin Virol"},{"key":"10.1016\/j.diagmicrobio.2026.117405_bib0012","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/QAI.0b013e31816b6ae6","article-title":"National survey of prevalent HIV strains: limited genetic variation of Korean HIV-1 clade B within the population of Korean men who have sex with men","volume":"48","author":"Kim","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.diagmicrobio.2026.117405_bib0013","doi-asserted-by":"crossref","first-page":"832","DOI":"10.3390\/v17060832","article-title":"HIV-1 genetic diversity and transmitted drug resistance mutations in ART-na\u00efve individuals in South Korea from 2021 to 2024","volume":"17","author":"Kim","year":"2025","journal-title":"Virus"},{"key":"10.1016\/j.diagmicrobio.2026.117405_bib0014","doi-asserted-by":"crossref","first-page":"e00292","DOI":"10.1128\/JCM.00292-18","article-title":"Multicenter evaluation of two next-generation HIV-1 quantitation assays, Aptima Quant Dx and Cobas 6800, in comparison to the RealTime HIV-1 reference assay","volume":"56","author":"Wiesmann","year":"2018","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2026.117405_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2023.115951","article-title":"Clinical performance evaluation of the Aptima viral assays for the quantitation of HIV-1, HCV, and HBV in plasma samples","volume":"106","author":"Lewis","year":"2023","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2026.117405_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2025.117144","article-title":"Performance evaluation of the AccuPower HBV Quant assay compared to the Cobas 6800 HBV assay","volume":"114","author":"Mun","year":"2026","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2026.117405_bib0017","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1128\/JCM.36.6.1471-1479.1998","article-title":"Determinations of levels of human immunodeficiency virus type 1 RNA in plasma: reassessment of parameters affecting assay outcome. TUBE meeting workshop attendees. Technology utilization for HIV-1 blood evaluation and standardization in pediatrics","volume":"36","author":"Lew","year":"1998","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2026.117405_bib0018","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1128\/JCM.36.2.493-498.1998","article-title":"Stability of human immunodeficiency virus RNA in blood specimens as measured by a commercial PCR-based assay","volume":"36","author":"Sebire","year":"1998","journal-title":"J Clin Microbiol"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889326001550?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889326001550?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T02:02:20Z","timestamp":1785376940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889326001550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0732889326001550"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2026.117405","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of the AccuPower HIV-1 Quant Kit and Aptima HIV-1 Quant Dx Assay for quantification of HIV-1 plasma viral load","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2026.117405","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117405"}}